Evodia Rutaecarpa Powder Point Application Theropy Therapy Chemotherapy Curative Effect Observation Of Gastrointestinal Reaction

ObjectiveWestern medicine treatment of gastrointestinal reaction caused by colorectal cancer adjuvant chemotherapy drug variety, but the application of many drugs have their indications and contraindications, the curative effect of drug has certain limitations, and only western medicine still can’t fully control gastrointestinal reaction. Reaction of gastrointestinal tract symptoms such as nausea and vomiting, diarrhoea, appetite to reduce influence of adjuvant chemotherapy patients quality of life, serious patients had to interrupt chemotherapy, even influence the curative effect. So it to bear on the scattered points were applied in the observation of evodia rutaecarpa powder joint anti-nausea protecting stomach western medicine treatment of colorectal cancer after operation XELOX scheme the clinical curative effect of adjuvant chemotherapy of gastrointestinal reaction, compared to pure used anti-nausea protecting stomach western medicine curative effect, application of statistical software to evaluate the effect of the differences, to look forward to providing a new method for the treatment of chemotherapy of gastrointestinal reaction, and for the characteristics of traditional Chinese medicine therapy in clinical will provide new options.MethodsChoose meet eligibility criteria patients without exclusion criteria, for the first time into the patients were randomly assigned (A:treatment group B:observation group), each patient observation of two adjacent process in gastrointestinal tract reaction, adjuvant chemotherapy and ensure the two adjuvant chemotherapy into different categories. Using with the patient before and after the contrast and the overall control of different observation indexes between different groups, different indicators of observed between the two way mean t test for statistical analysis.ResultsAt the beginning of the number of vomiting in chemotherapy-after intravenous drip oxaliplatin into2hours, after intravenous drip oxaliplatin into2hours-after intravenous drip oxaliplatin into oral capecitabine2hours after the two times when a statistically significant (P<0.05),2hours after oral capecitabine-the second day morning period of no statistical difference (P>0.05); Appetite score between the two groups after static drops of oxaliplatin into2hours,2hours after an oral capecitabine, the second day morning three time points were statistically significant (P<0.05); Gross score between the two groups in the second day morning time point was statistically difference (P<0.05), after the static drops of oxaliplatin into2hours,2hours after an oral capecitabine time no statistical difference (P>0.05); Abdominal distension score between the two groups after intravenous drip oxaliplatin into2hours,2hours after an oral capecitabine, the second day morning three time points had no statistical difference (P>0.05).ConelusionEvodia rutaecarpa powder point application theropy zhongwan, yongquan point of XELOX schemes adjuvant chemotherapy low acute vomiting, loss of appetite has good curative effect, can’t evaluate the curative effect of nausea, but for abdominal pain, diarrhea, abdominal distension is invalid. Evodia rutaecarpa powder point application theropy zhongwan, yongquan point can be used as an auxiliary treatment with western medicine anti-nausea protecting stomach medication XELOX solution caused by adjuvant chemotherapy of gastrointestinal reaction.